Vol 83, No 3 (2025)
Short communication
Published online: 2025-01-03
Is etiology the dominant modifier of prognosis in all heart failure phenotypes?
Abstract
Not available
References
- Rywik TM, Doryńska A, Wiśniewska A, et al. Epidemiology and clinical characteristics of hospitalized patients with heart failure with reduced, mildly reduced, and preserved ejection fraction. Pol Arch Intern Med. 2022; 132(5): 16227.
- Niedziela JT, Rozentryt P, Nowak J, et al. Characteristics and outcomes for patients with heart failure diagnosed according to the universal definition and classification of heart failure. Data from a single-center registry. Pol Heart J. 2024; 82(4): 391–397.
- Vedin O, Lam CSP, Koh AS, et al. Significance of ischemic heart disease in patients with heart failure and preserved, midrange, and reduced ejection fraction: a nationwide cohort study. Circ Heart Fail. 2017; 10(6): e003875.
- Chioncel O, Lainscak M, Seferovic PM, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017; 19(12): 1574–1585.
- Cleland JGF, McGowan J. Heart failure due to ischaemic heart disease: Epidemiology, pathophysiology and progression. J Cardiovasc Pharmacol . 1999; 33(Suppl 3): S17–S29.
- Villaschi A, Pagnesi M, Stolfo D, et al. Ischemic etiology in advanced heart failure: Insight from the HELP-HF registry. Am J Cardiol. 2023; 204: 268–275.
- Vicent L, Guerra J, Vazquez-García R, et al. Ischemic etiology and prognosis in men and women with acute heart failure. J Clin Med. 2021; 10(8): 1713.
- Frazier CG, Alexander KP, Newby LK, et al. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: A pooled analysis of 5 randomized control trials. J Am Coll Cardiol. 2007; 49(13): 1450–1458.
- Rywik TM, Wiśniewska A, Cegłowska U, et al. Heart failure with reduced, mildly reduced, and preserved ejection fraction: Outcomes and predictors of prognosis. Pol Arch Intern Med. 2023; 133(12): 16522.
- Vergaro G, Ghionzoli N, Innocenti L, et al. Noncardiac versus cardiac mortality in heart failure with preserved, midrange, and reduced ejection fraction. J Am Heart Assoc. 2019; 8(20): e013441.
